Literature DB >> 2547718

Invasion of HeLa 229 cells by virulent Bordetella pertussis.

C A Ewanowich1, A R Melton, A A Weiss, R K Sherburne, M S Peppler.   

Abstract

Phase-dependent invasive behavior of Bordetella pertussis was demonstrated by recovery of viable organisms from gentamicin-treated HeLa cell monolayers and by transmission electron microscopy. Several mutants of B. pertussis with Tn5 or Tn5 lac inserted into various vir-regulated genes were evaluated for differences in their invasive abilities. Mutants lacking filamentous hemagglutinin, pertussis toxin, and two as yet uncharacterized vir-regulated products had levels of invasion significantly lower than that of the parent strain BP338. In contrast, invasion by mutants lacking adenylate cyclase toxin was significantly increased compared with that of wild-type B. pertussis. This increase in invasion was eliminated when concentrations of intracellular cyclic 3'-5' AMP were stimulated by treating HeLa cells with cholera toxin or forskolin. Entry of B. pertussis occurred through a microfilament-dependent phagocytic process, as evidenced by the marked reduction in uptake following treatment of HeLa cells with cytochalasin D. Invasion was inhibited with polyclonal anti-B. pertussis and anti-filamentous hemagglutinin antisera. In addition, a monoclonal antibody against lipooligosaccharide A reduced uptake by 65.5%. The preservation of HeLa cell integrity and the limited replication of intracellular bacteria suggest that invasion may represent a means by which B. pertussis evades an active host immune response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547718      PMCID: PMC313514          DOI: 10.1128/iai.57.9.2698-2704.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  An electron-microscope study of intracerebral infection of mice with low-virulence Bordetella pertussis.

Authors:  J W Hopewell; L B Holt; T R Desombre
Journal:  J Med Microbiol       Date:  1972-02       Impact factor: 2.472

2.  Macrophage behaviour during the complaisant phase of murine pertussis.

Authors:  C Cheers; D F Gray
Journal:  Immunology       Date:  1969-12       Impact factor: 7.397

3.  Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells.

Authors:  W E Goldman; D G Klapper; J B Baseman
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

4.  The steady state in cellular immunity. II. Immunological complaisance in murine pertussis.

Authors:  D F Gray; C Cheers
Journal:  Aust J Exp Biol Med Sci       Date:  1967-08

5.  Shigella infection of henle intestinal epithelial cells: role of the host cell.

Authors:  T L Hale; R E Morris; P F Bonventre
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

6.  Phagocyte impotence caused by an invasive bacterial adenylate cyclase.

Authors:  D L Confer; J W Eaton
Journal:  Science       Date:  1982-09-03       Impact factor: 47.728

7.  Extracytoplasmic adenylate cyclase of Bordetella pertussis.

Authors:  E L Hewlett; M A Urban; C R Manclark; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

8.  Bordetella pertussis-induced hyperinsulinaemia without marked hypoglycaemia: a paradox explained.

Authors:  B L Furman; A C Wardlaw; L Q Stevenson
Journal:  Br J Exp Pathol       Date:  1981-10

9.  STUDIES ON THE LYMPHOCYTOSIS INDUCED IN MICE BY BORDETELLA PERTUSSIS.

Authors:  S I MORSE
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

10.  The depression of phagocytosis by exogenous cyclic nucleotides, prostaglandins, and theophylline.

Authors:  J P Cox; M L Karnovsky
Journal:  J Cell Biol       Date:  1973-11       Impact factor: 10.539

View more
  65 in total

1.  Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis.

Authors:  L Bassinet; P Gueirard; B Maitre; B Housset; P Gounon; N Guiso
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Phagocytosed Bordetella pertussis fails to survive in human neutrophils.

Authors:  D H Lenz; C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis.

Authors:  J W Petersen; P H Ibsen; K Hasløv; I Heron
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

5.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes.

Authors:  L L Steed; E T Akporiaye; R L Friedman
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

7.  Bordetella pertussis adenylate cyclase-hemolysin induces interleukin-6 secretion by human tracheal epithelial cells.

Authors:  Laurence Bassinet; Catherine Fitting; Bruno Housset; Jean-Marc Cavaillon; Nicole Guiso
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells.

Authors:  C A Guzman; M Rohde; M Bock; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides.

Authors:  A Banemann; H Deppisch; R Gross
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract.

Authors:  Kelly D Elder; Eric T Harvill
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.